INOD vs JKS

INOD presents a stark contrast between a clean balance sheet and severe valuation and technical deterioration. With a Piotroski F-Score of 4/9 (Stable) and a Graham Number of $8.28, the stock is trading at a massive premium to its deterministic fair value. While the company maintains a very low debt-to-equity ratio (0.04) and strong ROE (37.76%), these are offset by negative earnings growth (-19.4% YoY) and a catastrophic 6-month price decline of 57.3%. The disconnect between the analyst target price ($91.25) and the current price action suggests a significant market correction is underway.

JKS exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic YoY EPS decline of 1548.3%. While the stock appears cheap on a Price-to-Book (0.51) and Price-to-Sales (0.02) basis, these are classic 'value trap' indicators given the negative profit margins and crashing revenue growth. The dividend is fundamentally unsustainable with a payout ratio of 388.48%, suggesting the company is returning capital it does not have. Despite bullish analyst targets, the deterministic health metrics signal a high risk of further deterioration.